Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 4,139	$ 4,233
Trade accounts receivable, less allowance for doubtful accounts of $80 and $40, respectively	11,108	11,054
Prepaid expenses	3,914	3,480
Income taxes receivable	528	141
Other current assets	520	692
Total current assets	20,209	19,600
Net property and equipment	40,474	38,269
Intangible assets, net	2,227	2,616
Goodwill	66,152	66,152
Deferred contract costs, net	2,498	1,562
Other noncurrent assets	3,318	4,340
Total assets	134,878	132,539
Current liabilities:
Current portion of notes payable, net of unamortized debt issuance costs	4,014	4,789
Accounts payable	1,169	1,194
Accrued wages and bonuses	7,218	4,774
Accrued expenses	2,897	5,091
Dividends payable	3,625	2,770
Deferred revenue	16,201	15,786
Income Taxes Payable	550	353
Other current liabilities	946	1,101
Total current liabilities	36,620	35,858
Notes payable, net of current portion and unamortized debt issuance costs	75,021	57,895
Deferred income taxes	5,984	3,531
Other long-term liabilities	3,263	3,971
Total liabilities	120,888	101,255
Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued	0	0
Common stock, $0.001 par value; authorized 110,000,000 shares, issued 31,966,504 in 2025 and 31,072,144 in 2024, outstanding 22,637,252 in 2025 and 23,083,116 in 2024	32	31
Additional paid-in capital	183,880	180,249
Accumulated deficit	(17,298)	(17,064)
Treasury stock, 9,329,252 and 7,989,028 Common shares in 2025 and 2024, respectively, at cost	(152,624)	(131,932)
Total shareholders’ equity	13,990	31,284
Total liabilities and shareholders’ equity	$ 134,878	$ 132,539